Abstract
Keith A. Josephs, Stephen D. Weigand, Ryota Satoh, Anna Lavrova, Amanda L. Tapia, Jonathan Graff-Radford, Mary M. Machulda, Kejal Kantarci, Bradley F. Boeve, Ronald C. Petersen, Clifford R. Jack, Dennis W. Dickson, Aivi T. Nguyen, R. Ross Reichard, Val J. Lowe, Jennifer L. Whitwell
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Alzheimer's disease
10.1038/nrdp.2015.56 · 2015
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years
10.1097/nen.0b013e318232a379 · 2011
The Ultrastructure of the Neurofibrillary Tangle and the Senile Plaque
1970
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
10.1016/j.jalz.2011.03.005 · 2011
Hippocampal excitatory amino acid receptors in elderly, normal individuals and those with Alzheimer's disease: non-N-methyl-D-aspartate receptors
10.1016/0306-4522(92)90379-g · 1992
Focal cortical presentations of Alzheimer's disease
10.1093/brain/awm213 · 2007
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
10.1016/s1474-4422(14)70090-0 · 2014
New insights into atypical Alzheimer's disease in the era of biomarkers
10.1016/s1474-4422(20)30440-3 · 2021
Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation
10.1007/s00401-019-02036-6 · 2019
Four distinct trajectories of tau deposition identified in Alzheimer's disease
10.1038/s41591-021-01309-6 · 2021
[(18) F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
10.1002/ana.25142 · 2018
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
10.1212/wnl.41.4.479 · 1991
Diagnosis of Alzheimer's disease
10.1001/archneur.1985.04060100083029 · 1985
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease
1997
Phases of A beta-deposition in the human brain and its relevance for the development of AD
10.1212/wnl.58.12.1791 · 2002
Neuropathological stageing of Alzheimer-related changes
10.1007/bf00308809 · 1991
Diagnostic criteria for neuropathologic assessment of Alzheimer's disease
10.1016/s0197-4580(97)00062-6 · 1997
Frequency of stages of Alzheimer-related lesions in different age categories
10.1016/s0197-4580(97)00056-0 · 1997
From sensation to cognition
10.1093/brain/121.6.1013 · 1998
The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture
10.1093/cercor/bhw157 · 2016
Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques
10.1073/pnas.87.6.2249 · 1990
Molecular neuropathology of Alzheimer's disease: in situ hybridization studies
10.1007/bf00733642 · 1990
[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
10.1016/j.jalz.2012.11.008 · 2013
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)
10.2967/jnumed.109.069088 · 2010
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
10.1002/ana.20009 · 2004
PET of brain amyloid and tau in mild cognitive impairment
10.1056/nejmoa054625 · 2006
Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies
10.1007/s00259-019-04397-2 · 2019
Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
10.2967/jnumed.115.171678 · 2016
An autoradiographic evaluation of AV-1451 Tau PET in dementia
10.1186/s40478-016-0315-6 · 2016
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
10.1007/s00401-017-1740-8 · 2017
Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias
10.1016/j.jalz.2016.01.003 · 2016
Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration
10.1002/ana.25893 · 2020
Flortaucipir PET uncovers relationships between tau and amyloid-beta in primary age-related tauopathy and Alzheimer's disease
10.1126/scitranslmed.ado8076 · 2024
Association of in vivo retention of [(18)f] flortaucipir pet with tau neuropathology in corresponding brain regions
10.1007/s00401-024-02801-2 · 2024
Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
10.1001/jamaneurol.2020.0528 · 2020
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases
10.1093/brain/awaa276 · 2020
Investigating the feasibility of (18)F-flortaucipir PET imaging in the antemortem diagnosis of primary age-related tauopathy (PART): An observational imaging-pathological study
10.1002/alz.14301 · 2024
Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy-confirmed co-pathologies
10.1002/alz.71092 · 2026
Association of [(18)F]Flortaucipir-PET and Plasma p-Tau217 With Tau Neuropathology in Alzheimer Disease and Other Neurodegenerative Disorders
10.1212/wnl.0000000000214576 · 2026
Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross-Sectional Tau Positron Emission Tomography
10.1002/ana.26479 · 2022
brms: An R Package for Bayesian Multilevel Models Using Stan
10.18637/jss.v080.i01 · doi-reference
A harmonized classification system for FTLD-TDP pathology
10.1007/s00401-011-0845-8 · doi-reference
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
10.1016/j.jalz.2011.10.007 · doi-reference
Single-day apolipoprotein E genotyping
10.1016/0165-0270(94)90168-6 · doi-reference
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
10.1002/mds.26987 · doi-reference
Criteria for the diagnosis of corticobasal degeneration
10.1212/wnl.0b013e31827f0fd1 · doi-reference
Primary progressive aphasia--differentiation from Alzheimer's disease
10.1002/ana.410220414 · doi-reference
Classification of primary progressive aphasia and its variants
10.1212/wnl.0b013e31821103e6 · doi-reference
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
10.1093/brain/awr179 · doi-reference
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
10.1212/wnl.43.2.250 · doi-reference
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
10.1212/wnl.0000000000004058 · doi-reference
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features
10.1093/brain/awv191 · doi-reference
Consensus classification of posterior cortical atrophy
10.1016/j.jalz.2017.01.014 · doi-reference
Mild cognitive impairment as a diagnostic entity
10.1111/j.1365-2796.2004.01388.x · doi-reference
A new clinical scale for the staging of dementia
10.1192/bjp.140.6.566 · doi-reference
“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
10.1016/0022-3956(75)90026-6 · doi-reference
The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics
10.1159/000115751 · doi-reference
Data-driven decomposition and staging of flortaucipir uptake in Alzheimer's disease
10.1002/alz.13769 · doi-reference
APOE effects on regional tau in preclinical Alzheimer's disease
10.1186/s13024-022-00590-4 · doi-reference
Effect of APOE epsilon4 genotype on amyloid-beta and tau accumulation in Alzheimer's disease
10.1186/s13195-020-00710-6 · doi-reference
Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET
10.1212/wnl.0000000000011270 · doi-reference
APOE epsilon4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease
10.1002/alz.12711 · doi-reference
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study
10.1002/ana.26382 · doi-reference
Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females
10.1093/brain/awad397 · doi-reference
Sex differences in the association of Alzheimer's disease biomarkers and cognition in a multicenter memory clinic study
10.1186/s13195-025-01684-z · doi-reference
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis
10.1001/jamaneurol.2025.0013 · doi-reference
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
10.1093/brain/awaa327 · doi-reference
Longitudinal tau PET in ageing and Alzheimer's disease
10.1093/brain/awy059 · doi-reference
Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
10.1016/j.nicl.2019.101823 · doi-reference
Motor features in posterior cortical atrophy and their imaging correlates
10.1016/j.neurobiolaging.2014.05.028 · doi-reference
Is the pathology of posterior cortical atrophy clinically predictable?
10.1515/revneuro-2022-0003 · doi-reference
Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases
10.1002/mds.27252 · doi-reference
AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies
10.1002/ana.24825 · doi-reference
The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease
10.1016/j.jalz.2018.12.016 · doi-reference
Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes
10.1093/brain/awaa155 · doi-reference
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
10.1093/brain/aww027 · doi-reference
MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
10.1002/acn3.51038 · doi-reference
In vivo Patterns of Tau Pathology, Amyloid-beta Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease
10.3233/jad-160316 · doi-reference
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia
10.1093/brain/aws076 · doi-reference
The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases
10.1016/0168-0102(92)90014-4 · doi-reference